SCHEMBL26260084

SCHEMBL26260084

COc1ccc2c(-c3cncnc3)c(OC)ccc2c1-c1cncnc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 1/20 0.44
▸ EPAS1 Q99814 1/20 0.44
▸ ERN1 O75460 2/20 0.44
▸ NPC1 O15118 1/20 0.41
▸ CYP19A1 P11511 4/20 0.41
▸ CYP11B1 P15538 4/20 0.41
▸ CYP11B2 P19099 4/20 0.41
▸ CYP17A1 P05093 2/20 0.41
▸ MAPT P10636 3/20 0.38
▸ KLK3 P07288 1/20 0.36
▸ MAP4K1 Q92918 1/20 0.36
▸ FGFR4 P22455 1/20 0.36
▸ ATM Q13315 1/20 0.35
▸ PLAU P00749 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ S1PR4 O95977 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ G6PD P11413 1/20 0.35
▸ S1PR1 P21453 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26260092 0.79 NPC1 (0.60) ERN1NPC1CYP19A1CYP11B1CYP11B2
SCHEMBL26260037 0.78 CYP11B1 (0.53) ERN1CYP11B1CYP11B2CYP17A1KDM4E
SCHEMBL26259638 0.78 HIF1A (0.46) HIF1AEPAS1ERN1NPC1CYP17A1
SCHEMBL19899679 0.74 CYP19A1 (0.33) ERN1NPC1CYP19A1CYP11B1CYP11B2
SCHEMBL26259629 0.72 MAPT (0.52) HIF1AEPAS1NPC1MAPTKDM4E
SCHEMBL3388407 0.70 FABP3 (0.51) NPC1KDM4EHTTRAB9AALDH1A1
SCHEMBL17751247 0.69 CYP19A1 (0.54) ERN1NPC1CYP19A1CYP11B1CYP11B2
SCHEMBL28743751 0.69 ERN1 (0.53) ERN1CYP11B1CYP11B2CYP17A1MAPT
SCHEMBL13915445 0.69 ATM (0.56) CYP11B1CYP11B2ATMALDH1A1EGFR
SCHEMBL26260090 0.68 ECE1 (0.49) HIF1AEPAS1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 HIF1A 3592/4885EPAS1 3942/4885ERN1 2995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback